文献速递乳房整形与再造

乳房切除术后放疗下临时扩张器与永久假体的长期重建失败结果

Long-Term Results and Reconstruction Failure in Patients Receiving Postmastectomy Radiation Therapy with a Temporary Expander or Permanent Implant in Place.
PubMed 文献 · Plast Reconstr Surg · 2020-01-01

单机构回顾性研究比较乳房切除术后即刻重建并放疗时,组织扩张器/永久假体组(63例)与永久假体组(75例)的长期重建失败风险。中位随访116个月,传统比例风险模型显示扩张器/假体组失败风险更高(HR 2.01)且失败时间更短(109.2 vs 157.7个月,p=0.03),但竞争风险模型显示组间累积发生率无显著差异(HR 1.09)。

要点

  • 放疗下扩张器或永久假体均有较大远期重建失败风险
  • 传统模型示扩张器/假体组失败更早但竞争风险模型无差异
  • 需探索更复杂技术以降低放疗后重建失败风险

核心结论

  • 放疗至组织扩张器或永久假体均伴随相当大的远期重建失败风险。
  • 扩张器/假体组并不比永久假体组更易发生重建失败,但失败发生时间更短。

研究设计与样本

  • 按即刻重建类型分组织扩张器后续换永久假体组(63例)与永久假体组(75例)。
  • 终点为重建失败,定义为置换、假体丢失或转为皮瓣。

主要发现

  • 中位随访116个月,记录8例假体丢失、50例假体置换、4例转为皮瓣。
  • 扩张器/假体组22/63例、永久假体组40/75例发生重建失败。
  • 传统比例风险模型示扩张器/假体组失败风险更高(HR 2.01)。
  • 传统模型示扩张器/假体组失败时间更短(109.2个月 vs 157.7个月,p=0.03)。
  • 竞争风险模型示组间累积发生率无显著差异(HR 1.09)。

临床怎么用

  • 放疗前选择扩张器或永久假体时需充分告知远期重建失败风险。
  • 扩张器/假体组失败可能更早出现,应加强早期随访监测。

局限性

  • 单机构回顾性研究,样本量有限(63例与75例)。
  • 传统模型与竞争风险模型结果不一致,需谨慎解读组间差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study investigated the risk of reconstruction failure after mastectomy, immediate breast reconstruction, and radiotherapy to either a temporary tissue expander or permanent implant. METHODS: Records of women treated at a single institution between June of 1997 and December of 2011 were reviewed. Two patient groups were identified based on type of immediate breast reconstruction: tissue expander followed by exchange with a permanent implant and permanent implant. The study endpoint was rate of reconstruction failure, defined as a replacement, loss of the implant, or conversion to flap. RESULTS: The tissue expander/permanent implant and the permanent implant groups consisted of 63 and 75 patients, respectively. The groups were well balanced for clinical and treatment characteristics. With a median follow-up of 116 months, eight implant losses, 50 implant replacements, and four flap conversions were recorded. Reconstruction failure occurred in 22 of 63 patients in the expander/implant group and in 40 of 75 patients in the permanent implant group. A traditional proportional hazards model showed a higher risk of reconstruction failure for the expander/implant group (hazard ratio, 2.01) and a significantly shorter time to reconstruction failure compared with the permanent implant group (109.2 months versus 157.7 months; p = 0.03); however, according to a competing risk model, the between-groups cumulative incidences were not significantly different (hazard ratio, 1.09). CONCLUSIONS: Radiotherapy to either a tissue expander or a permanent implant presented a fairly large risk of reconstruction failure over time. The expander/implant group was not more likely to develop reconstruction failure compared to permanent implant group, but the timing of onset was shorter. More complex techniques should be investigated to lower the risk of reconstruction failure. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Dicuonzo S, Leonardi MC, Radice D, et al. Long-Term Results and Reconstruction Failure in Patients Receiving Postmastectomy Radiation Therapy with a Temporary Expander or Permanent Implant in Place. Plast Reconstr Surg. 2020. PMID: 31985612. doi:10.1097/PRS.0000000000006441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。